Klea Holding SA (EPA:ALKLH)
France
· Delayed Price · Currency is EUR 0.200
-0.005 (-2.40%)
Mar 9, 2026, 5:35 PM CET
Klea Holding Revenue
Klea Holding had revenue of 11.46M EUR in the half year ending June 30, 2025, with 79.58% growth. This brings the company's revenue in the last twelve months to 20.86M, up 37.41% year-over-year. In the year 2024, Klea Holding had annual revenue of 17.26M with 25.93% growth.
Revenue (ttm)
20.86M
Revenue Growth
+37.41%
P/S Ratio
3.01
Revenue / Employee
178.30K
Employees
117
Market Cap
62.78M
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 17.26M | 3.55M | 25.93% |
| Dec 31, 2023 | 13.71M | -739.00K | -5.12% |
| Dec 31, 2022 | 14.45M | 7.27M | 101.38% |
| Dec 31, 2021 | 7.17M | -11.85M | -62.30% |
| Dec 31, 2020 | 19.03M | 8.76M | 85.27% |
| Dec 31, 2019 | Pro | Pro | Pro |
| Dec 31, 2018 | Pro | Pro | Pro |
| Dec 31, 2017 | Pro | Pro | Pro |
| Dec 31, 2016 | Pro | Pro | Pro |
| Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| EssilorLuxottica Société anonyme | 28.49B |
| Sanofi | 46.72B |
| Sartorius Stedim Biotech | 2.97B |
| Ipsen | 3.93B |
| AB Science | 1.03M |
| Eurofins-Cerep | 38.86M |
| OSE Immunotherapeutics | 1.78M |
| Valerio Therapeutics Société anonyme | 1.83M |